BioTuesdays

Tag - Geoffrey Porges

Opthea-Logo
Markets

SVB Leerink starts Opthea at OP; PT $33

SVB Leerink launched coverage of Opthea (NASDAQ:OPT) with an “outperform” rating and $33 price target. The stock closed at $13.19 on Nov. 10. “The basis for our recommendation and valuation is our forecast for revenue...

November 11, 2020
ResTORbio
Markets

SVB Leerink cuts ResTORbio to MP; PT to $2 from $40

SVB Leerink downgraded ResTORbio (NASDAQ:TORC) to “market perform” from “outperform” and slashed its price to $2 from $40 after a failure of first of the company’s two ongoing Phase 3 trials in respiratory infection...

November 15, 2019